The treatment of obesity with drugs

被引:10
作者
Hirsch, J [1 ]
机构
[1] Rockefeller Univ, New York, NY 10021 USA
关键词
D O I
10.1093/ajcn/67.1.2
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
[No abstract available]
引用
收藏
页码:2 / 4
页数:3
相关论文
共 9 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]  
AUERBACH JG, 1997, WALL ST J 0916, pB1
[3]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[4]   LONG-TERM WEIGHT-LOSS - THE EFFECT OF PHARMACOLOGICAL AGENTS [J].
GOLDSTEIN, DJ ;
POTVIN, JH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 60 (05) :647-657
[6]   Pharmacotherapy for obesity - Do the benefits outweigh the risks? [J].
Manson, JE ;
Faich, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :659-660
[7]   Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine - A systematic review of the evidence [J].
McCann, UD ;
Seiden, LS ;
Rubin, LJ ;
Ricaurte, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (08) :666-672
[8]  
PROUIX LG, 1997, WASHINGTON POST S, P13
[9]   LONG-TERM WEIGHT CONTROL STUDY .5. (WEEKS 190 TO 210) - FOLLOW-UP OF PARTICIPANTS AFTER CESSATION OF MEDICATION [J].
WEINTRAUB, M ;
SUNDARESAN, PR ;
SCHUSTER, B ;
AVERBUCH, M ;
STEIN, EC ;
BYRNE, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :615-618